Long-term debt · 2011–2025

Pacira Biosciences long-term debt

$372M−3.0% · FY2025

Pacira Biosciences (PCRX) reported $372M in long-term debt for fiscal 2025, −3.0% year on year.

$18.5M2011$25.2M2012$02013$103M2014$104M2015$109M2016$689M2022$522M2023$384M2024$372M2025
Pacira Biosciences — Long-term debt, 2011–2025
Fiscal yearLong-term debtChangeFiling
FY20252025-12-31$372M−3.0%Open →
FY20242024-12-31$384M−26.6%Open →
FY20232023-12-31$522M−24.2%Open →
FY20222022-12-31$689M+534.1%Open →
FY20162016-12-31$109M+4.5%Open →
FY20152015-12-31$104M+0.9%Open →
FY20142014-12-31$103M+$103MOpen →
FY20132013-12-31$0−100.0%Open →
FY20122012-12-31$25.2M+35.9%Open →
FY20112011-12-31$18.5M—Open →

Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +23.9%

Long-term debt at companies of similar size

Full ranking by long-term debt →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Pacira Biosciences long-term debt |url=https://companiesranked.com/en/company/pacira-biosciences/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Pacira Biosciences long-term debt. CompaniesRanked. https://companiesranked.com/en/company/pacira-biosciences/long-term-debt

BibTeX

@misc{companiesranked-en-company-pacira-biosciences-long-term-debt-2026,
  author       = {{CompaniesRanked}},
  title        = {{Pacira Biosciences long-term debt}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/pacira-biosciences/long-term-debt}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001628280-26-052635 · August 4, 2026

{{cite web |title=Pacira Biosciences long-term debt — 10-Q (0001628280-26-052635) |url=https://www.sec.gov/Archives/edgar/data/1396814/000162828026052635/pcrx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Pacira Biosciences overview